drugset / Trial / NCT00873197
PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV Granisetron
NaSingle-groupOpen-labelOther
Summary
This study has been designed to investigate the pharmacokinetic and safety profile of the co-administration of intravenous (IV) and transdermal granisetron, as well as characterise the pharmacokinetics of multiple transdermal dosing.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Granisetron | Other / unclassified | 0.01 mg/kg | Intravenous |
| Subject | Granisetron | Other / unclassified | 3.1 mg | Intravenous |
Indications
No indication recorded.